SULT1E1 polymorphisms are shown to be a risk factor for breast and endometrial cancers, [11] suggesting that its modulation might be an attractive strategy in the prevention, management and or treatment of breast cancer. The gene discussed is SULT1E1; the disease is breast carcinoma.